IRBS Financial Statements From 2010 to 2025
| IRBSDelisted Stock | USD 0.0001 0.00 0.00% |
Check IR Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IR Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . IRBS financial statements analysis is a perfect complement when working with IR Biosciences Valuation or Volatility modules.
IRBS |
IR Biosciences Holdings Company Shares Outstanding Analysis
IR Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current IR Biosciences Shares Outstanding | 17.08 M |
Most of IR Biosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IR Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, IR Biosciences Holdings has 17.08 M of shares currently outstending. This is 87.48% lower than that of the Biotechnology sector and 39.54% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.01% higher than that of the company.
IR Biosciences Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IR Biosciences's current stock value. Our valuation model uses many indicators to compare IR Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IR Biosciences competition to find correlations between indicators driving IR Biosciences's intrinsic value. More Info.IR Biosciences Holdings is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value IR Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About IR Biosciences Financial Statements
IR Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although IR Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IR Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IR Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona. Ir Biosciences operates under Research Services classification in the United States and is traded on OTC Exchange. It employs 4 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in IRBS Stock
If you are still planning to invest in IR Biosciences Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IR Biosciences' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |